Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Study of Plasmin (Human) Infusion Regimens in Acute Lower Extremity Arterial or Bypass Graft Occlusion
2010-019760-36Phase 2Completed
- Sponsor
- Grifols
- Start
- Jul 2010
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of plasmin in Acute limb ischaemia (ALI) and peripheral artery occlusion (PAD) (6 arms), sponsored by Grifols. Started Jul 2010; status: completed.
02
Drugs
plasmin
03
Conditions
Acute limb ischaemia (ALI)peripheral artery occlusion (PAD)
Beyond the preview
Go deeper on 2010-019760-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019760-36.